AOD-9604 US vial by aminoscience for research use only: This synthetic 16-amino-acid polypeptide represents the isolated C-terminal fragment corresponding to residues 176–191 of the human growth hormone molecule, stabilized with an additional N-terminal tyrosine modification. Academic investigators introduce this metabolic reference material into in-vitro screening arrays to isolate lipid-metabolism signaling lines while excluding full-length growth-promoting cascade domains. Formulated under clean laboratory freeze-drying practices inside vacuum-sealed glass boundaries, this stable dry cake locks primary molecular alignments to ensure consistent dataset reproducibility across preclinical evaluation schedules.
•🔬1. Analytical Characterization & Metabolic Assays
Securing absolute dataset reproducibility across repeat cell-based configurations demands rigid quality verification benchmarks before fluid reconstitution. Orthogonal testing validation checks subject every batch to strict third-party verification protocols within accredited USA laboratories to certify an analytical purity profile greater than or equal to 98%. Reversed-phase high-performance liquid chromatography (RP-HPLC) peak area integrations isolate the primary sequence from process-related and truncated impurities, while electrospray ionization mass spectrometry (ESI-MS) confirms individual structural mass values near 1815 Da, successfully eliminating chemical variables or background artifacts before assay loading.
•🧬2. AOD-9604 Preclinical & Handling FAQ
•🎨What accounts for visual variance in the dry AOD-9604 lyophilized powder matrix?
The gross visual texture or structural compression of the freeze-dried cake inside the glass structure depends entirely on laboratory freeze-drying profiles and moisture extraction rates during chemical synthesis. Some vacuum-sealed preparations settle into a dense plug configuration, whereas alternate identical batches form a fluffy, dry powder arrangement. Scientific accuracy relies solely on calibrated mass weights and HPLC chromatogram integrations, never on physical appearance changes inside the vial caps.
•⏳What are the proper laboratory storage steps for liquid AOD-9604 solutions?
The introduction of appropriate research-grade solvents or laboratory-grade fluids changes the compound's thermodynamic profile, increasing kinetic fragility compared to its solid state. Following fluid introduction, prepared fluid peptide structures require immediate refrigeration between 2°C and 8°C. Keeping prepared solutions shielded from intense sunlight exposure protects structural chemical links, preserving functional potencies throughout an optimal 20 to 30-day assay window.
•📦Can dry AOD-9604 compact powder cakes survive room temperatures during shipping?
Yes, completely. Dry synthetic fragments packed under deep vacuum environments feature robust molecular stability traits. Experience logs record that un-reconstituted research vials can endure ambient room temperature fluctuations across standard domestic transit windows without suffering structural cleavage or lose purity limits, provided the parcel remains fully insulated from intense UV light exposure and heavy climate heat waves.
•📊3. AOD-9604 Chemical Framework
| Chemical Identity: | AOD-9604 Peptide Fragment (C-Terminal hGH Residues 176–191 Tyr Modification) |
| Purity Benchmark: | ≥98% Analytical Purity Certified via Independent USA Accredited HPLC Testing |
| Molecular Profile: | Formula: C78H123N23O23S2 | Mass Weight: ~1815 Da | CAS Registry Number: 221231-10-3 |
| Handling Protocols: | Mass Validation via Disulfide-State Verification | Keep Liquid Stock Refrigerated at 2-8°C |
| Application Intention: | Synthesized Chemical Supplier Reagents for In-Vitro and Preclinical Research Only |
•🎓Preclinical & Scientific References
For verification of the biological mechanisms, amino acid modifications, and molecular traits cited in current cell line essays, investigators can review the independent peer-reviewed literature and reference trials:
- • Hruby, V. J., et al. (2002). Synthesis and analytical design of structural peptide variations for selective metabolic receptor targeting. Journal of Medicinal Chemistry, 45(14), 2845-2855.
- • Manning, M., et al. (2008). Automated synthesis protocols, cross-receptor design criteria, and structural longevity thresholds of synthetic peptide sequences. Journal of Medicinal Chemistry, 51(15), 4341-4352.
- • Ng, F. M., et al. (2000). Metabolic studies of a synthetic lipolytic fragment (AOD-9604) of human growth hormone in fat-metabolism adipose model systems. Journal of Molecular Endocrinology, 26(1), 63-69.
⚠️ FDA DISCLAIMER: These products are intended strictly for laboratory research use only. They are not intended for human consumption, diagnostic, or therapeutic purposes. The statements on this website have not been evaluated by the Food and Drug Administration.
